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B. contaminans is the most frequent species of the B. cepacia complex (Bcc) isolated
from CF patients in Argentina. There is little data on the virulence and clinical
impact of this Bcc member over CF patients’ health.
To assess characteristics of B. contaminans associated with different courses of
infection, colonies recovered from A) patients with a unique isolate (n = 3) and B)
ﬁrst and last isolates of chronically infected patients (n = 3), were compared. Two
patients of this last group died.
RAPD genetic comparation, antibiotics resistance proﬁle, virulence on the alfalfa
model, bioﬁlm formation, motility, haemolysis, green-yellow pigment and mucoid
phenotype were studied.
Colonies recovered from A and ﬁrst isolates from B were very similar and
displayed haemolytic activity, pigment production, and mucoid expression. Among
last isolates collected from the two dead patients, some colonies with nonmucoid
phenotype, low motility and bioﬁlm formation, no haemolytic activity nor pigment
production were found. There were no signiﬁcant differences of virulence in the
alfalfa model assays.
Main differences were found in RAPD and the antibiotic resistance proﬁles: colonies
collected from A group shared the same RAPD pattern and were susceptible to all
antibiotics tested. However, only one colony of the ﬁrst isolate from B group had
this antibiotic proﬁle. First and last isolates of the two dead patients showed genetic
changes.
These results suggest genetic and phenotypic changes during the course of the
infection by B. contaminans. Although a phenotype was detected at the last stage
of infection, more virulence related to the alfalfa model could not be demonstrated.
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S. aureus is a serious pathogen of CF patients. Altogether 1532 S. aureus isolates
were recovered from 237 CF patients in 2009–2011. Isogenic strains of wild type
and SCV S. aureus resistant to macrolides-lincosamides-streptogramin B (MLSB)
and/or aminoglycosides or MRSA were analyzed. Comparison of culture and PCR
(duplex PCR − nuc, Sa2052) for the detection of S. aureus from the patient
sputa revealed that as many as 40% of culture-negative samples were positive by
PCR. The isolates were typed by pulsed-ﬁeld gel electrophoresis (PFGE) and spa
typing and some of them also by multilocus sequence typing. All isolates studied
were of unique types. A small proportion of the MRSA isolates analyzed (n = 3)
showed an identical PFGE pattern and the same spa type. Around one third of
the isolates were resistant to MLSB antibiotics while aminoglycoside resistance
was much less frequent. The isolates were screened for MLSB resistance genes
(ermA, ermB, ermC and msrA) and aminoglycoside resistance genes (aacA-aphD,
aphA3, aadC). In a large proportion (around one third) of the isolates, none of these
resistance genes was detected. SCV strains, all but one auxotrophic to thymidine.
The highly sensitive duplex PCR could be a valuable tool for detecting early stage
infection with S. aureus in infants or for assessing treatment efﬁcacy in CF patients.
S. aureus isolates from CF and non-CF patients may differ substantially in biological
properties. Their role in the pathogenesis of the disease is still unclear.
This work was supported by grant NT12395−5/2011 from the Internal Grant Agency
of the Ministry of Health of the Czech Republic.
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Background: Burkholderia cepacia complex (Bcc), currently consisting of 17
species, is an important cause of morbidity and mortality in CF. B. cenocepacia
and B. multivorans are the most commonly isolated species.
Method:Medical ﬁles of all CF patients ever infected with Bcc in the period 1998–
2012 were reviewed. For each Bcc-infected patient, a control patient was matched
for age, gender and genotype.
Results: Over this 14 year-period, 18 patients were infected with Bcc: 10 were
chronically infected (8 B. multivorans, 1 B. vietnamensis, 1 B. stabilis) and 8 were
transiently infected. Prevalence of Bcc varied annually with a maximum of 4%.
Both groups, Bcc and control, had equal co-infection rates for Ps. aeruginosa (50
vs 40%, p = 0.34) and S. maltophilia (11 vs 22%, p = 0.37). However, in the group
chronically infected with Bcc, none had co-infection with S. maltophilia (vs 50%
in transient Bcc; p< 0.5). In each group 1 patient died (1 B. multivorans and 1
control). Mean FEV1 1 and 2 years before and after acquisition was lower in Bcc
than controls, but statistically not signiﬁcant. At time of Bcc acquisition, FEV1 was
signiﬁcantly lower (p< 0.5).
Conclusion: Prevalence of Bcc in our centre is stable and low. Bcc infections are
predominantly caused by B. multivorans; B. cenocepacia infections did not occur.
Bcc infection was not associated with a faster clinical deterioration. Lower lung
function values at time of acquisition, suggest an association of Bcc acquisition
and pulmonary exacerbation.
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Objectives: CF lung disease is associated with diverse bacteria chronically infecting
the airways. Slow-growing, antibiotic-resistant mutants of S. aureus known as
small-colony variants (SCVs) have been isolated from respiratory secretions from
European adults and children with CF using speciﬁc but infrequently-used culture
techniques. S. aureus SCVs can be selected either by exposure to speciﬁc antibiotics
or by growth with P. aeruginosa. We sought to determine the prevalence, clinical
signiﬁcance, and likely mechanisms of selection of S. aureus SCVs among a US
cohort of children with CF.
Methods: We performed a two-year study of 100 children with CF using culture
techniques sensitive for S. aureus SCVs, and evaluated associations with clinical
characteristics using multivariable regression models.
Results: S. aureus SCV infection was detected among 24% of participants and
was signiﬁcantly associated with a much greater lung function decline during
the study (p = 0.007, adjusted for enrollment age and lung function), even after
adjusting for infection with other known CF pathogens, including P. aeruginosa and
methicillin-resistant S. aureus. Evidence indicated S. aureus SCVs were selected
in vivo by treatment with trimethoprim-sulfamethoxazole and by co-infection with
P. aeruginosa.
Conclusion: SCV S. aureus infection was independently associated with poorer
CF respiratory outcomes in this pediatric cohort. As many clinical microbiology
laboratories do not speciﬁcally detect S. aureus SCVs, validation and extension of
these ﬁndings would require widespread changes in the usual laboratory and clinical
approach to these bacteria.
